October 30th, 2019|
According to the New York Times, major drugstore retailers have pulled Zantac off of their shelves due to certain versions of the heartburn medication containing potentially cancer-causing ingredients.
The pharmacy chains recently announced that they were no longer selling the product after the Food and Drug Administration issued a statement in September 2019 saying that Zantac and its generic form, ranitidine, may contain high levels of N-nitrosodimethylamine (NDMA), a human carcinogen.
If you’re looking for an experienced drug injury lawyer to help you pursue justice and compensation in a Zantac lawsuit, call (877) 562-0000 today or fill out the online consultation form on this page.
F.D.A Warns of Zantac Cancer Risks
The U.S. Food and Drug Administration (FDA) announced that it is investigating Zantac cancer risks. Recent testing of Zantac tablets found that the commonly-used heartburn medication contains a potentially dangerous carcinogenic chemical up to 26,000 times greater than the FDA’s daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”).
What Is NDMA?
N-nitrosodimethylamine is a semi-volatile chemical that belongs to a class of known potent carcinogens, according to the U.S. Environmental Protection Agency (EPA). The industrial chemical is used in gasoline, as a stabilizer for industry materials, and as a lubricant additive. NDMA has also been used to make liquid rocket fuel, and is a byproduct of manufacturing certain pesticides and processing fish.
Does Zantac Cause Cancer?
Since the 1980s, studies have demonstrated a link between the NDMA in Zantac and cancer. Mounting evidence also shows that Sanofi and Boehringer Ingelheim, the big pharma companies that make Zantac (ranitidine), concealed the Zantac cancer link from millions of people who took the drug for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux and other issues.
This deception came as the companies made unprecedented profits from Zantac, the first drug to generate $1 billion in sales.
With countless people stricken with cancer after taking Zantac, many are turning to the courts and filing a Zantac lawsuit to hold large pharmaceutical companies like Sanofi and Boehringer Ingelheim accountable for their reckless disregard for human health and willingness to put profit over people.
What are the Long-Term Side Effects Linked to Zantac NDMA Exposure?
Long-term exposure to Zantac or its generic active ingredient, ranitidine, can lead to an increased risk of developing cancer. Side effects of Zantac include:
- Bladder cancer
- Colon and Rectal cancer
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Lung cancer (non-smokers)
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Testicular cancer
- Thyroid cancer
- Uterine cancer
Which Zantac Brands and Products Contain Ranitidine?
Some of the most common Zantac brands include:
- Zantac 150 Tablets
- Zantac 150 Maximum Strength
- Zantac 150 Maximum Strength Cool Mint
- Zantac 75 Tablets
- Wal-Zan 150
- Wal-Zan 75
- Heartburn Relief (ranitidine)
- Acid Reducer (ranitidine)
- Acid Control (ranitidine)
How Can a Zantac Lawsuit Help Me?
If you’ve been injured by Zantac, we know you’ve suffered emotionally and economically, and want to work with you personally to obtain the maximum compensation for the damages caused by your injuries. Contact us today to learn more about your legal rights! Call (877) 562-0000 now.